Award winning executive search to the private, and investor backed health, care, and life sciences sectors
Trusted executive search partner to the investment community delivering outstanding leaders for the healthcare and life sciences sectors
0
Mandates delivered to date
0
%
Delivery rate of all retained mandates
0
%
C-suite appointments are women
0
+
Sub-sectors in healthcare and life sciences supported
Healthcare news, data and analysis
Via Investors in Healthcare
Switzerland: Oculis raises US$100m from underwritten share issue

Switzerland: Oculis raises US$100m from underwritten share issue
February 14, 2025
Healthcare
News
Ophthalmology
Public Equity
Arctica Finance
Insights into Germany’s wheelchair market

Insights into Germany’s wheelchair market
February 14, 2025
Analysis
Articles
Healthcare
Life Sciences
Medtech – Hospital Equipment
France: Bio-Rad enters agreement to acquire Stilla Technologies

France: Bio-Rad enters agreement to acquire Stilla Technologies
February 14, 2025
Life Sciences
M&A
News
Pharma
Bio-Rad Laboratories
Japan: Bain Capital to acquire Mitsubishi Tanabe Pharma Corp for JPY510bn

Japan: Bain Capital to acquire Mitsubishi Tanabe Pharma Corp for JPY510bn
February 13, 2025
Buy Out
M&A
Manufacturing – Specialty Pharma
News
Pharma
London: Vora rejoins Oliver Wyman as partner in Healthcare an Life Sciences and Private Capital practices

London: Vora rejoins Oliver Wyman as partner in Healthcare an Life Sciences and Private Capital practices
February 13, 2025
Healthcare
Life Sciences
People
Pharma
Chris McMillan
Netherlands: Enovation acquires Performation from Gilde Healthcare

Netherlands: Enovation acquires Performation from Gilde Healthcare
February 13, 2025
Buy Out
Digital Health/Healthtech
Healthcare
M&A
A&O Shearman
Sweden: John Stubbington to replace Fredrik Rågmark as CEO of Medicover

Sweden: John Stubbington to replace Fredrik Rågmark as CEO of Medicover
February 12, 2025
Diagnostics
Healthcare
People
Fredrik Rågmark
Fredrik Stenmo
UK: Acquisitions and strategic expansion across the CDMO value chain prioritised to accelerate Avid Bioservices growth

UK: Acquisitions and strategic expansion across the CDMO value chain prioritised to accelerate Avid Bioservices growth
February 11, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
UK: Jan De Witte joins GHO Capital as operating partner

UK: Jan De Witte joins GHO Capital as operating partner
February 11, 2025
Healthcare
People
Pharma
GHO Capital Partners
Jan De Witte
Switzerland: Novonesis paying dsm-firmenich €1.5bn to dissolve Feed Enzyme Alliance

Switzerland: Novonesis paying dsm-firmenich €1.5bn to dissolve Feed Enzyme Alliance
February 11, 2025
M&A
Manufacturing – Specialty Pharma
News
Pharma
Denmark
Switzerland: Novartis to acquire Anthos Therapeutics for up to US$3.1bn

Switzerland: Novartis to acquire Anthos Therapeutics for up to US$3.1bn
February 11, 2025
M&A
Manufacturing – Specialty Pharma
News
Pharma
Anthos Therapeutics
Germany: Gerresheimer confirms takeover approach from private equity

Germany: Gerresheimer confirms takeover approach from private equity
February 10, 2025
Buy Out
M&A
News
Pharma
Public Equity
UK: Amethyst Radiotherapy UK appoints Sasha Burns as new CEO

UK: Amethyst Radiotherapy UK appoints Sasha Burns as new CEO
February 10, 2025
Clinical Labs
Digital Health/Healthtech
Healthcare
Hospitals and Clinics
People
Italy: Vesper Next Generation Infrastructure Fund I completes interim close

Italy: Vesper Next Generation Infrastructure Fund I completes interim close
February 10, 2025
Diagnostics
Healthcare
News
European Investment Fund (EIF)
Generali Lion River
The Netherlands: Asker Healthcare acquires Mayumana Healthcare

The Netherlands: Asker Healthcare acquires Mayumana Healthcare
February 7, 2025
Diagnostics
Distribution
Healthcare
M&A
News
Belgium: Gimv raises €247m from rights issue

Belgium: Gimv raises €247m from rights issue
February 7, 2025
Healthcare
Life Sciences
News
Pharma
Public Equity
UK: Pioneer appoints Chris Walters to drive European expansion

UK: Pioneer appoints Chris Walters to drive European expansion
February 7, 2025
Life Sciences
News
People
Pharma
Real Estate
Switzerland: BioVersys shares begin trading on SIX Swiss

Switzerland: BioVersys shares begin trading on SIX Swiss
February 7, 2025
Manufacturing – Specialty Pharma
News
Pharma
Public Equity
AMR Action Fund
UK: Adam Thorpe joins Stax in London to lead EMEA healthcare vertical

UK: Adam Thorpe joins Stax in London to lead EMEA healthcare vertical
February 7, 2025
Healthcare
Life Sciences
People
Pharma
Social Care
Germany: Lauxera invests in German neurovascular medical device company

Germany: Lauxera invests in German neurovascular medical device company
February 6, 2025
Buy Out
M&A
News
Acandis
Germany
Sweden: Safe Life adds to portfolio with acquisition of Life Safety Solutions

Sweden: Safe Life adds to portfolio with acquisition of Life Safety Solutions
February 6, 2025
Life Sciences
M&A
Medtech – Hospital Equipment
News
Dave Magruder
France: Proteor expands digital solutions with Filament Innovations

France: Proteor expands digital solutions with Filament Innovations
February 6, 2025
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Edouard Archambeaud
UK: Liva Healthcare acquires Discover Momenta and secures new backing

UK: Liva Healthcare acquires Discover Momenta and secures new backing
February 5, 2025
Buy Out
Consumer Healthcare
Healthcare
M&A
News
US: MedPharm appoints Bill Humphries as CEO

US: MedPharm appoints Bill Humphries as CEO
February 5, 2025
People
Pharma
Services – CRO/CMO/CDMO
Ampersand Capital Partners
Bill Humphries
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.

A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors












What our clients say

“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair

“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery

“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer

“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer

“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director

“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer

“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer

“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director

“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO

“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
The latest insights from
Compass Carter Osborne
Speak to our experts
Whether you’re looking to secure talented leaders for your business, or find a new role, Compass Carter Osborne can be trusted to deliver.